Vanessa Brizuela
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Vanessa Brizuela has a total of 309 co-authors. Here are the top co-authors by number of shared publications:
Anna Thorson
UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), Department of Sexual, Reproductive, Maternal, Child, Adolescent Health and Ageing, World Health Organization, Geneva, Switzerland
9 shared publicationsMercedes Bonet
UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), Department of Sexual and Reproductive Health and Research, World Health Organization, Geneva, Switzerland
8 shared publications- Mercedes Bonet
UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), Department of Sexual and Reproductive Health and Research, World Health Organization, Geneva, Switzerland
8 shared publications - Jessica Lynn Schue
Department of International Health, Johns Hopkins Bloomberg School of Public Health, 615 N Wolfe Street, Baltimore, MD 21205, USA
6 shared publications - Jose Guilherme Cecatti
Department of Obstetrics and Gynecology, University of Campinas, Brazil
6 shared publications - Marleen Temmerman
Aga Khan University Centre of Excellence in Women and Child Health, P.O. Box 30270 - 00100, Nairobi, Kenya
6 shared publications
Latest Publications
- Open Access
- 20 May 2026
- Published by Public Library of Science (PLoS) in PLOS Climate
- Vol. 5 (5) , e0000835
Research priorities in sexual and reproductive health and rights and climate change: Results of a consensus building and prioritisation process
Recent literature suggests that climate change can impact sexual and reproductive health and rights (SRHR) outcomes, especially since climate-related events may exacerbate persistent inequalities based on gender, disability status, sexual orientation, and age, among others. Climate change can also impact health infrastructure with an impact on SRHR access and outcomes. However, data are scarce when it comes to certain topical areas, types of evidence, and in using an intersectional approach. Based on a prior expert consultation exercise, we conducted a consensus and priority setting process to develop a list of priority research questions at the intersection of climate change and SRHR. For this, in 2024, we completed an iterative process over three rounds consisting of online surveys and consultations, following modified Delphi and Child Health and Nutrition Research Initiative (CHNRI) methodologies for which 100 people were included. For round one, 56 people responded to the 17-question survey framed around topical areas in SRHR, research methodologies, and intersectionality; 39 people participated in the online consultation. The round two survey had 36 respondents and 41 participants to the online consultation. The third round included a survey with a list of 31 questions that respondents were asked to prioritize. A final list of ten questions emerged which highlighted important areas where there continue to be gaps in evidence, including maternal and perinatal health, contraception and abortion access, and gender-based violence. Other critical areas include intersectional issues regarding gender and poverty and comprehensive sex education. The list can serve as a starting point to guide the SRHR research community to generate the evidence needed for policy action.
- 20 May 2026
- Published by Public Library of Science (PLoS) in PLOS Climate
- Vol. 5 (5) , e0000835
Open AccessResearch priorities in sexual and reproductive health and rights and climate change: Results of a consensus building and prioritisation process
Recent literature suggests that climate change can impact sexual and reproductive health and rights (SRHR) outcomes, especially since climate-related events may exacerbate persistent inequalities based on gender, disability status, sexual orientation, and age, among others. Climate change can also impact health infrastructure with an impact on SRHR access and outcomes. However, data are scarce when it comes to certain topical areas, types of evidence, and in using an intersectional approach. Based on a prior expert consultation exercise, we conducted a consensus and priority setting process to develop a list of priority research questions at the intersection of climate change and SRHR. For this, in 2024, we completed an iterative process over three rounds consisting of online surveys and consultations, following modified Delphi and Child Health and Nutrition Research Initiative (CHNRI) methodologies for which 100 people were included. For round one, 56 people responded to the 17-question survey framed around topical areas in SRHR, research methodologies, and intersectionality; 39 people participated in the online consultation. The round two survey had 36 respondents and 41 participants to the online consultation. The third round included a survey with a list of 31 questions that respondents were asked to prioritize. A final list of ten questions emerged which highlighted important areas where there continue to be gaps in evidence, including maternal and perinatal health, contraception and abortion access, and gender-based violence. Other critical areas include intersectional issues regarding gender and poverty and comprehensive sex education. The list can serve as a starting point to guide the SRHR research community to generate the evidence needed for policy action.
- Open Access
- 12 February 2026
- Published by Springer Nature in BMC Public Health
- Vol. 26 (1)
Satisfaction and experience of care among women with abortion-related complications from Africa and Latin America and the Caribbean
Although abortion is a frequent event in women’s reproductive life and abortion-related complications have negative consequences for women’s he
- 12 February 2026
- Published by Springer Nature in BMC Public Health
- Vol. 26 (1)
Open AccessSatisfaction and experience of care among women with abortion-related complications from Africa and Latin America and the Caribbean
Although abortion is a frequent event in women’s reproductive life and abortion-related complications have negative consequences for women’s he
- Open Access
- 28 January 2026
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 6 (1) , e0004562
Pregnant women’s attitudes and intentions toward tuberculosis, malaria, group B streptococcus, and respiratory syncytial virus vaccines in pregnant: Findings from a cross-sectional study of pregnant women living in Brazil, Ghana, Kenya, and Pakistan
There are numerous infections that can adversely impact a developing fetus, neonates, and pregnant women, and there is limited research related to how specific infections experienced during pregnancy can affect these populations. Tuberculosis (TB), malaria, Group B streptococcus (GBS) and respiratory syncytial virus (RSV) can cause negative outcomes to maternal and neonatal health. For TB and GBS, there are vaccines in various stages of clinical trial development, and malaria and RSV vaccines are available. This study aimed to examine pregnant women’s attitudes toward TB, malaria, GBS, and RSV vaccines in Brazil, Ghana, Kenya, and Pakistan. We administered a cross-sectional survey to pregnant women, recruiting women seeking care in primarily urban health facilities. We surveyed 1,603 pregnant women. Participants indicated that vaccine safety for the baby was the most important factor in their decision-making related to vaccine acceptance, followed by vaccine efficacy for the baby, and then vaccine safety for the mother. When asked why they would receive any of the four vaccines, participants indicated that protecting the baby was most important, followed by protecting self, and then stopping the spread of disease. Almost one-third of participants (30%) indicated that they would definitely intend to receive a GBS vaccine, followed by malaria (26%), RSV (25%), and TB (19%). Related to vaccine hesitancy, approximately 40% of our participants agreed that vaccines are unnatural, 38% agreed that the body should develop natural immunity, and 19% had delayed a recommended vaccine. Pregnant women are interested in receiving various vaccines while pregnant. As several new adult vaccines are on the horizon, understanding the attitudes of potential vaccine beneficiaries at higher risk for diseases is critical for informing clinical trial design and, in the long term, vaccine acceptance.
- 28 January 2026
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 6 (1) , e0004562
Open AccessPregnant women’s attitudes and intentions toward tuberculosis, malaria, group B streptococcus, and respiratory syncytial virus vaccines in pregnant: Findings from a cross-sectional study of pregnant women living in Brazil, Ghana, Kenya, and Pakistan
There are numerous infections that can adversely impact a developing fetus, neonates, and pregnant women, and there is limited research related to how specific infections experienced during pregnancy can affect these populations. Tuberculosis (TB), malaria, Group B streptococcus (GBS) and respiratory syncytial virus (RSV) can cause negative outcomes to maternal and neonatal health. For TB and GBS, there are vaccines in various stages of clinical trial development, and malaria and RSV vaccines are available. This study aimed to examine pregnant women’s attitudes toward TB, malaria, GBS, and RSV vaccines in Brazil, Ghana, Kenya, and Pakistan. We administered a cross-sectional survey to pregnant women, recruiting women seeking care in primarily urban health facilities. We surveyed 1,603 pregnant women. Participants indicated that vaccine safety for the baby was the most important factor in their decision-making related to vaccine acceptance, followed by vaccine efficacy for the baby, and then vaccine safety for the mother. When asked why they would receive any of the four vaccines, participants indicated that protecting the baby was most important, followed by protecting self, and then stopping the spread of disease. Almost one-third of participants (30%) indicated that they would definitely intend to receive a GBS vaccine, followed by malaria (26%), RSV (25%), and TB (19%). Related to vaccine hesitancy, approximately 40% of our participants agreed that vaccines are unnatural, 38% agreed that the body should develop natural immunity, and 19% had delayed a recommended vaccine. Pregnant women are interested in receiving various vaccines while pregnant. As several new adult vaccines are on the horizon, understanding the attitudes of potential vaccine beneficiaries at higher risk for diseases is critical for informing clinical trial design and, in the long term, vaccine acceptance.
- Open Access
- 1 December 2025
- Published by Springer Nature in Reproductive Health
- Vol. 22 (S3) , 280
Responding to the COVID-19 pandemic through global partnerships: the case of the HRP Alliance for research capacity strengthening
Background: The UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP) has a mandate to lead in sexual and reproductive health and rights research and to support research capacity strengthening. Starting in 2016, it did so through supporting the latter through a large network of research institutions called the HRP Alliance. This commentary highlights the work of the HRP Alliance in response to the coronavirus disease (COVID-19) pandemic. Main body: The onset of the COVID-19 pandemic prompted the HRP Alliance to adapt the way they had been working. HRP Alliance research capacity strengthening hubs actively contributed to developing a research agenda based on WHO’s research and development blueprint and country-specific needs. They also took on leading roles in developing, adapting to each country/setting, and implementing research projects aimed at understanding how the COVID-19 pandemic was affecting SRHR in different contexts and income settings. These studies provided opportunities for early career researchers and students to lead in project management, study implementation, training, and data analysis. Through a network of nimble research institutions, the HRP Alliance collaborated to generate evidence on the impact of COVID-19 on pregnancy, pregnancy outcomes, access to SRHR services, gender-based violence, and abortion care. The success of implementing these research response mechanisms and developing global networks of research and healthcare institutions, provided solid ground upon which to build SRHR research responses to future pandemics and other emerging diseases. Conclusion: Adequate readiness and response to global health emergencies require high quality and timely evidence generation. Global networks of research partner institutions, brought together through research capacity strengthening initiatives, can provide a fruitful platform ready and able to swiftly respond. However, inherent power imbalances and challenges to equitable partnerships need to be considered to ensure sustainable ways of working together.
- 1 December 2025
- Published by Springer Nature in Reproductive Health
- Vol. 22 (S3) , 280
Open AccessResponding to the COVID-19 pandemic through global partnerships: the case of the HRP Alliance for research capacity strengthening
Background: The UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP) has a mandate to lead in sexual and reproductive health and rights research and to support research capacity strengthening. Starting in 2016, it did so through supporting the latter through a large network of research institutions called the HRP Alliance. This commentary highlights the work of the HRP Alliance in response to the coronavirus disease (COVID-19) pandemic. Main body: The onset of the COVID-19 pandemic prompted the HRP Alliance to adapt the way they had been working. HRP Alliance research capacity strengthening hubs actively contributed to developing a research agenda based on WHO’s research and development blueprint and country-specific needs. They also took on leading roles in developing, adapting to each country/setting, and implementing research projects aimed at understanding how the COVID-19 pandemic was affecting SRHR in different contexts and income settings. These studies provided opportunities for early career researchers and students to lead in project management, study implementation, training, and data analysis. Through a network of nimble research institutions, the HRP Alliance collaborated to generate evidence on the impact of COVID-19 on pregnancy, pregnancy outcomes, access to SRHR services, gender-based violence, and abortion care. The success of implementing these research response mechanisms and developing global networks of research and healthcare institutions, provided solid ground upon which to build SRHR research responses to future pandemics and other emerging diseases. Conclusion: Adequate readiness and response to global health emergencies require high quality and timely evidence generation. Global networks of research partner institutions, brought together through research capacity strengthening initiatives, can provide a fruitful platform ready and able to swiftly respond. However, inherent power imbalances and challenges to equitable partnerships need to be considered to ensure sustainable ways of working together.
- Open Access
- 3 November 2025
- Published by BMJ in BMJ Global Health
- Vol. 10 (11) , e020907
Embedding research capacity strengthening in multicountry sexual health research
Research capacity strengthening (RCS) is fundamental for advancing sustainable sexual and reproductive health and rights (SRHR) research. This article examines how RCS was embedded into the CoTSIS study, a multicountry cognitive testing initiative across 19 countries based on existing frameworks and experience. We offer lessons learnt for others intending to embed RCS in multicountry research implementation. The CoTSIS study incorporated RCS at all stages of study implementation. Capacity strengthening was incorporated in study start-up through the application and selection process of study teams, protocol co-creation and adaptation of the study tool into 15 languages. RCS was also embedded through training of study teams in cognitive interviewing techniques, ethics and sensitive research methods using a flipped classroom approach, as well as by providing ongoing support during data collection and during joint analysis and results write-up. There were several lessons learnt from this experience, such as: (1) include RCS goals and budget during study planning; (2) plan for training and needs assessments; (3) benefit from the advantages of online tools; (4) budget resources for knowledge translation activities; and (5) plan for assessing sustained capacity strengthened. By embedding specific and intentional RCS goals and activities, multicountry studies can contribute to long-lasting and sustainable RCS, encouraging power shifts and country ownership.
- 3 November 2025
- Published by BMJ in BMJ Global Health
- Vol. 10 (11) , e020907
Open AccessEmbedding research capacity strengthening in multicountry sexual health research
Research capacity strengthening (RCS) is fundamental for advancing sustainable sexual and reproductive health and rights (SRHR) research. This article examines how RCS was embedded into the CoTSIS study, a multicountry cognitive testing initiative across 19 countries based on existing frameworks and experience. We offer lessons learnt for others intending to embed RCS in multicountry research implementation. The CoTSIS study incorporated RCS at all stages of study implementation. Capacity strengthening was incorporated in study start-up through the application and selection process of study teams, protocol co-creation and adaptation of the study tool into 15 languages. RCS was also embedded through training of study teams in cognitive interviewing techniques, ethics and sensitive research methods using a flipped classroom approach, as well as by providing ongoing support during data collection and during joint analysis and results write-up. There were several lessons learnt from this experience, such as: (1) include RCS goals and budget during study planning; (2) plan for training and needs assessments; (3) benefit from the advantages of online tools; (4) budget resources for knowledge translation activities; and (5) plan for assessing sustained capacity strengthened. By embedding specific and intentional RCS goals and activities, multicountry studies can contribute to long-lasting and sustainable RCS, encouraging power shifts and country ownership.
- Open Access
- 24 September 2025
- Published by Taylor & Francis in Sexual and Reproductive Health Matters
- Vol. 33 (1) , 1-22
Shaping the WHO Sexual Health Assessment of Practices and Experiences questionnaire: a descriptive study on the real-world example from Portugal
Sexual health is a major dimension of global health and wellbeing. Yet, evidence regarding its assessment at a worldwide level is scarce. Most population-based studies are conducted in a limited number of countries from the Global North using specific measures that do not allow for country comparison. The World Health Organization (WHO) led a process to create a global survey called the Sexual Health Assessment of Practices and Experiences (SHAPE) to assess sexual practices and behaviours that impact on health. This article aims to describe the application and feasibility of this questionnaire in an extended real-world context. It presents the results of the implementation process in Portugal, the first country to use it with a nationally representative sample. This descriptive study was conducted between 14th June and 15th October 2023, involving a sample of 2010 individuals (52% women) living in Portugal, aged 18-95 (mean = 49.6 years). 1426 participants responded online and 584 by telephone. Overall response rate was 30.9% (79.5% online, 12.4% by telephone) and 94% of responses were valid. The original SHAPE questionnaire took 17.7 minutes to answer on average (16.6 minutes online and 20.3 minutes by telephone). Including module G (assessing sexual problems), average time was 29.2 minutes. The relatively short response time and choice of formats suggest this tool provides a comprehensive picture of sexual health. It is hoped that it will be widely used in different health and research contexts, to enhance the global evidence base for the development of policies that promote sexual health.This article aims to describe the application and feasibility of this questionnaire in an extended real-world context.
- 24 September 2025
- Published by Taylor & Francis in Sexual and Reproductive Health Matters
- Vol. 33 (1) , 1-22
Open AccessShaping the WHO Sexual Health Assessment of Practices and Experiences questionnaire: a descriptive study on the real-world example from Portugal
Sexual health is a major dimension of global health and wellbeing. Yet, evidence regarding its assessment at a worldwide level is scarce. Most population-based studies are conducted in a limited number of countries from the Global North using specific measures that do not allow for country comparison. The World Health Organization (WHO) led a process to create a global survey called the Sexual Health Assessment of Practices and Experiences (SHAPE) to assess sexual practices and behaviours that impact on health. This article aims to describe the application and feasibility of this questionnaire in an extended real-world context. It presents the results of the implementation process in Portugal, the first country to use it with a nationally representative sample. This descriptive study was conducted between 14th June and 15th October 2023, involving a sample of 2010 individuals (52% women) living in Portugal, aged 18-95 (mean = 49.6 years). 1426 participants responded online and 584 by telephone. Overall response rate was 30.9% (79.5% online, 12.4% by telephone) and 94% of responses were valid. The original SHAPE questionnaire took 17.7 minutes to answer on average (16.6 minutes online and 20.3 minutes by telephone). Including module G (assessing sexual problems), average time was 29.2 minutes. The relatively short response time and choice of formats suggest this tool provides a comprehensive picture of sexual health. It is hoped that it will be widely used in different health and research contexts, to enhance the global evidence base for the development of policies that promote sexual health.This article aims to describe the application and feasibility of this questionnaire in an extended real-world context.
- Open Access
- 21 April 2025
- Published by BMJ in BMJ Global Health
- Vol. 10 (4) , e015815
Global maternal mortality associated with SARS-CoV-2 infection: a systematic review and meta-analysis
Background: Pregnant and recently pregnant women infected with SARS-CoV-2 are at increased risk of death and serious complications than those without the infection. The extent of variation in mortality rates in pregnant women with SARS-CoV-2 infection across regions, and the causes of death are not known. We systematically reviewed all available evidence on the variation in mortality rates in pregnant women with SARS-CoV-2 infection across geographical and country income groups, and the reported cause of death. Methods: We searched major databases (December 2019–January 2023) including Medline, LILACS, BIREME and Embase. We included studies that reported deaths in at least 10 consecutive pregnant or recently pregnant women with confirmed SARS-CoV-2 infection and assessed the studies’ risk of bias. We calculated the summary estimates of any cause of death as proportions with 95% CIs using a multilevel random-effects logistic regression model. Subgroup analyses were performed by geographical region and country income groups. We used International Statistical Classification of Diseases and Related Health Problems-Maternal Mortality to categorise the reported cause of death. Findings: From 1 326 315 citations, we included 169 studies (319 172 women with confirmed SARS-CoV-2 infection; 4253 women died). The overall rate of unspecified maternal death was 0.87% (95% CI 0.64% to 1.16%). There were significant differences between geographical regions in rates of maternal mortality, with the highest rates in Sub-Saharan Africa (3.48%; 95% CI 0.66% to 16.42%) and Latin America and the Caribbean (3.16%, 95% CI 1.53% to 6.43%). Rates of maternal mortality varied by country income groups, with the highest rates in low-income countries (4.66%, 95% CI 0.75% to 24.07%). Among women with reported cause of death, 98.6% (2,390/2,423) of deaths were attributable to COVID-19. Interpretation: Rates of deaths in pregnant and recently pregnant women with SARS-CoV-2 infection vary significantly across regions and by country income groups, with the highest burden in Sub-Saharan Africa and low-income countries. COVID-19 is the main reported cause of death. PROSPERO registration number: CRD42020224120.
- 21 April 2025
- Published by BMJ in BMJ Global Health
- Vol. 10 (4) , e015815
Open AccessGlobal maternal mortality associated with SARS-CoV-2 infection: a systematic review and meta-analysis
Background: Pregnant and recently pregnant women infected with SARS-CoV-2 are at increased risk of death and serious complications than those without the infection. The extent of variation in mortality rates in pregnant women with SARS-CoV-2 infection across regions, and the causes of death are not known. We systematically reviewed all available evidence on the variation in mortality rates in pregnant women with SARS-CoV-2 infection across geographical and country income groups, and the reported cause of death. Methods: We searched major databases (December 2019–January 2023) including Medline, LILACS, BIREME and Embase. We included studies that reported deaths in at least 10 consecutive pregnant or recently pregnant women with confirmed SARS-CoV-2 infection and assessed the studies’ risk of bias. We calculated the summary estimates of any cause of death as proportions with 95% CIs using a multilevel random-effects logistic regression model. Subgroup analyses were performed by geographical region and country income groups. We used International Statistical Classification of Diseases and Related Health Problems-Maternal Mortality to categorise the reported cause of death. Findings: From 1 326 315 citations, we included 169 studies (319 172 women with confirmed SARS-CoV-2 infection; 4253 women died). The overall rate of unspecified maternal death was 0.87% (95% CI 0.64% to 1.16%). There were significant differences between geographical regions in rates of maternal mortality, with the highest rates in Sub-Saharan Africa (3.48%; 95% CI 0.66% to 16.42%) and Latin America and the Caribbean (3.16%, 95% CI 1.53% to 6.43%). Rates of maternal mortality varied by country income groups, with the highest rates in low-income countries (4.66%, 95% CI 0.75% to 24.07%). Among women with reported cause of death, 98.6% (2,390/2,423) of deaths were attributable to COVID-19. Interpretation: Rates of deaths in pregnant and recently pregnant women with SARS-CoV-2 infection vary significantly across regions and by country income groups, with the highest burden in Sub-Saharan Africa and low-income countries. COVID-19 is the main reported cause of death. PROSPERO registration number: CRD42020224120.
- Open Access
Pregnant women’s attitudes and intentions toward tuberculosis, malaria, group B streptococcus, and respiratory syncytial virus vaccines in pregnant: Findings from pregnant women living in Brazil, Ghana, Kenya, and Pakistan
Introduction There are numerous infections that can adversely impact a developing fetus, neonates, and pregnant women, and there is limited research related to how specific infections experienced during pregnancy can affect these populations. Tuberculosis (TB), malaria, Group B streptococcus (GBS) and respiratory syncytial virus (RSV) can cause negative outcomes to maternal and neonatal health. For TB and GBS, there are vaccines in various stages of clinical trial development, and malaria and RSV vaccines are available. This study aimed to examine pregnant women’s attitudes toward TB, malaria, GBS, and RSV vaccines in Brazil, Ghana, Kenya, and Pakistan. Methods We administered a cross-sectional survey to pregnant women, recruiting women seeking care in primarily urban health facilities. Results We surveyed 1,603 pregnant women. Participants indicated that vaccine safety for the baby was the most important factor in their decision-making related to vaccine acceptance, followed by vaccine efficacy for the baby, and then vaccine safety for the baby. When asked why they would receive any of the four vaccines, participants indicated that protecting the baby was most important, followed by protecting self, and then stopping the spread of disease. Almost one-third of participants (30%) indicated that they would definitely intend to receive a GBS vaccine, followed by malaria (26%), RSV (25%), and TB (19%). Related to vaccine hesitancy, approximately 40% of our participants agreed that vaccines are unnatural, 38% agreed that the body should develop natural immunity, and 19% had delayed a recommended vaccine. Discussion Pregnant women are interested in receiving various vaccines while pregnant. As several new adult vaccines are on the horizon, understanding the attitudes of potential vaccine beneficiaries at higher risk for diseases is critical for informing clinical trial design and, in the long term, vaccine acceptance.
Open AccessPregnant women’s attitudes and intentions toward tuberculosis, malaria, group B streptococcus, and respiratory syncytial virus vaccines in pregnant: Findings from pregnant women living in Brazil, Ghana, Kenya, and Pakistan
Introduction There are numerous infections that can adversely impact a developing fetus, neonates, and pregnant women, and there is limited research related to how specific infections experienced during pregnancy can affect these populations. Tuberculosis (TB), malaria, Group B streptococcus (GBS) and respiratory syncytial virus (RSV) can cause negative outcomes to maternal and neonatal health. For TB and GBS, there are vaccines in various stages of clinical trial development, and malaria and RSV vaccines are available. This study aimed to examine pregnant women’s attitudes toward TB, malaria, GBS, and RSV vaccines in Brazil, Ghana, Kenya, and Pakistan. Methods We administered a cross-sectional survey to pregnant women, recruiting women seeking care in primarily urban health facilities. Results We surveyed 1,603 pregnant women. Participants indicated that vaccine safety for the baby was the most important factor in their decision-making related to vaccine acceptance, followed by vaccine efficacy for the baby, and then vaccine safety for the baby. When asked why they would receive any of the four vaccines, participants indicated that protecting the baby was most important, followed by protecting self, and then stopping the spread of disease. Almost one-third of participants (30%) indicated that they would definitely intend to receive a GBS vaccine, followed by malaria (26%), RSV (25%), and TB (19%). Related to vaccine hesitancy, approximately 40% of our participants agreed that vaccines are unnatural, 38% agreed that the body should develop natural immunity, and 19% had delayed a recommended vaccine. Discussion Pregnant women are interested in receiving various vaccines while pregnant. As several new adult vaccines are on the horizon, understanding the attitudes of potential vaccine beneficiaries at higher risk for diseases is critical for informing clinical trial design and, in the long term, vaccine acceptance.